Skip to content

Muscle Metabolism and Oxygenation During Localized Fatigue-exercise in COPD

Muscle Oxygenation and Metabolism in Response to a Localized Fatigue-inducing Exercise in Patients With Chronic Obstructive Pulmonary Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01909544
Enrollment
20
Registered
2013-07-26
Start date
2011-09-30
Completion date
Unknown
Last updated
2014-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Keywords

Pulmonary Disease, Chronic Obstructive, Muscle fatigue, Energy metabolism, Muscle oxygenation

Brief summary

The purpose of this study is to investigate whether a localized exercise, in which cardiorespiratory demand is reduced, will result in greater limb muscle fatigue in patients with COPD as a consequence of muscle oxygenation and muscle metabolism disturbances.

Interventions

All participants (patients and healthy subjects) will perform the exercise both under normoxic (FiO2 = 0.21) and hyperoxic conditions (FiO2 = 100%)

Sponsors

Canadian Lung Association
CollaboratorINDUSTRY
Laval University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* COPD (FEV1/FVC \< 0.70 and FEV1 \< 0.80 predicted * Healthy subjects: no evidence of airways obstruction (FEV1/FVC \> 0.70 and FEV1 \> 0.80 predicted) * Smoking history \> 15 pack-years

Exclusion criteria

* Chronic hypoxemia and/or hypercapnia (PaO2 \< 60 mmHg or SpO2 \< 88% at rest and/or PaCO2 \> 45 mmHg) * Recent exacerbation (\< 3 months) * Recent cancer (\< 3 years) * Diabetes * Myopathy, neuromuscular or articular disease * Unstable cardiac disease * Absolute contraindications to exercise testing * Regular physical activity or exercise training program in the last 2 months * Physical activity score \> 9 in the Voorips questionnaire * Thigh skinfold thickness \> 15 mm * BMI \> 30

Design outcomes

Primary

MeasureTime frameDescription
Muscle deoxygenation45 seconds post-exercise (knee-extension repetitions)Changes of deoxyhemoglobin/myoglobin concentrations measured by near-infrared spectroscopy of vastus lateralis muscle.
Muscle metabolism45 seconds post-exercise (knee extension repetitions)Changes in glycolytic and oxidative metabolism pathway markers, energy substrates (glycogen and glucose), end-products of glycolysis (pyruvate, and lactate), intermediate markers of glycolysis and high-energy phosphate compounds obtained from muscle biopsies

Secondary

MeasureTime frameDescription
Ventilatory responseBaseline, beginning and end of each serie of knee extensions (fatiguing exercise)Minute ventilation will be monitored during the fatigue-inducing exercise and it will be compared between subjects and conditions (FiO2 = 21% vs. FiO2 = 100%)
Quadriceps muscle fatiguebaseline, 15 min and 40 min after the fatigue-inducing exerciseQuadriceps muscle fatigue will be determined by loss of quadriceps strength measured by magnetic stimulation after the fatigue-inducing exercise. Surface electromyography will also be measured to characterize muscle fatigue.
total muscle workend of fatiguing exerciseTotal muscle work performed during fatigue-inducing exercise that will be composed by subsequent isokinetic knee-extensions repetitions at 40% of maximal peak torque

Countries

Canada

Contacts

Primary ContactFernanda Ribeiro, PhD candidate
fernanda.ribeiro@criucpq.ulaval.ca418-656-8711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026